Annual Report FY2025-26 filed; AGM on Sep 25 with RPT approvals

Related Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹2.83

prior close

₹2.83

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.5% vs market

Industrial Products peers, median of 134sector-0.5%+0.1% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.1 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+2.1

30m

+2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+0.1-0.5-0.5+0.1

Next day

-2.8-3.2+0.3-2.4-0.4

-2.1-3.3+1.2-3.4+1.3

-2.5-2.5+0.0-2.3-0.1

-2.1-0.9-1.2-2.1-0.0

+1.4-1.1+2.5-2.2+3.6

+3.5+0.6+2.9-0.4+4.0

15d

-0.4-1.4+1.0-1.3+0.9

-4.6-3.3-1.3-3.1-1.5

—————

UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 134Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Trans India House Impex filed its 38th Annual Report for FY2025-26 with BSE. The 38th AGM is scheduled for September 25, 2026 via video conferencing. Key agenda items include adopting audited standalone and consolidated financial statements, re-appointment of Mr. Mayank Suresh Jolly as director retiring by rotation, and approval of material related party transactions with four entities (Upwise Business Consultants, Trans India Ecofuel, Trans Infra Biz Buildcon, and TIHIL IDA Group), each capped at Rs 50 crore per transaction.

Likely market impact

Four related party transaction approvals of up to Rs 50 crore each are up for shareholder nod. Monitor related party concentration risk at AGM.